Bio-Sight Capital Co., Ltd.
VC · Ibaraki (Japan)
Sign up free to access full profile and submit your pitch.
About
Bio-Sight Capital Co., Ltd. is a private investment firm which specializes in incubation, seed, and early-stage companies. The firm prefers to invest in the biotechnology, life science and healthcare industries, specifically in the cell gene therapy treatment, therapeutic vaccines, drug discovery and new drug development, artificial organ development, new industrial materials, IT for hospital and new diagnostic equipment, genetic engineering, agri-bio, alternative energy, and environmental remediation technology. It primarily invests in the Osaka, Ibaraki, and the Kansai region, but extends also to the whole of Japan and worldwide. The firm has an equity investment between ¥30 million ($.36 million) to ¥50 million ($.60 million) in its portfolio companies. Bio-sight Capital Co., Ltd. was established on December 18, 2002 and is based in Osaka, Japan with additional offices in Tokyo, Japan.
Visit website ↗Investment Criteria
Sign up free to see full investment criteria and submit your pitch.
Co-Investors of Bio-Sight Capital Co., Ltd.
Other investors that have backed the same portfolio companies as Bio-Sight Capital Co., Ltd.. Expand any entry to see the shared portfolio companies.
- 6 shared
- 5 shared
Shared portfolio companies
- 3-D Matrix, Ltd.
- CanBas Co., Ltd.
- Hokkaido Venture Capital, Inc.
- Kringle Pharma, Inc.
- Soiken Holdings Inc.
- 5 shared
Shared portfolio companies
- 5 shared
Shared portfolio companies
- 4 shared
Shared portfolio companies
